141 related articles for article (PubMed ID: 31978754)
1. Estrogen Induces Mammary Ductal Dysplasia via the Upregulation of Myc Expression in a DNA-Repair-Deficient Condition.
Itou J; Takahashi R; Sasanuma H; Tsuda M; Morimoto S; Matsumoto Y; Ishii T; Sato F; Takeda S; Toi M
iScience; 2020 Feb; 23(2):100821. PubMed ID: 31978754
[TBL] [Abstract][Full Text] [Related]
2. Catechol estrogen quinones as initiators of breast and other human cancers: implications for biomarkers of susceptibility and cancer prevention.
Cavalieri E; Chakravarti D; Guttenplan J; Hart E; Ingle J; Jankowiak R; Muti P; Rogan E; Russo J; Santen R; Sutter T
Biochim Biophys Acta; 2006 Aug; 1766(1):63-78. PubMed ID: 16675129
[TBL] [Abstract][Full Text] [Related]
3. Estrogen promotes mammary tumor development in C3(1)/SV40 large T-antigen transgenic mice: paradoxical loss of estrogen receptoralpha expression during tumor progression.
Yoshidome K; Shibata MA; Couldrey C; Korach KS; Green JE
Cancer Res; 2000 Dec; 60(24):6901-10. PubMed ID: 11156389
[TBL] [Abstract][Full Text] [Related]
4. Estrogenic and antiestrogenic properties of resveratrol in mammary tumor models.
Bhat KP; Lantvit D; Christov K; Mehta RG; Moon RC; Pezzuto JM
Cancer Res; 2001 Oct; 61(20):7456-63. PubMed ID: 11606380
[TBL] [Abstract][Full Text] [Related]
5. Alterations in mammary gland development following neonatal exposure to estradiol, transforming growth factor alpha, and estrogen receptor antagonist ICI 182,780.
Hilakivi-Clarke L; Cho E; Raygada M; Kenney N
J Cell Physiol; 1997 Mar; 170(3):279-89. PubMed ID: 9066785
[TBL] [Abstract][Full Text] [Related]
6. Promotion of estrogen-induced mammary gland carcinogenesis by androgen in the male Noble rat: probable mediation by steroid receptors.
Liao DZ; Pantazis CG; Hou X; Li SA
Carcinogenesis; 1998 Dec; 19(12):2173-80. PubMed ID: 9886575
[TBL] [Abstract][Full Text] [Related]
7. Dietary γ-Tocopherol-Rich Mixture Inhibits Estrogen-Induced Mammary Tumorigenesis by Modulating Estrogen Metabolism, Antioxidant Response, and PPARγ.
Das Gupta S; Sae-tan S; Wahler J; So JY; Bak MJ; Cheng LC; Lee MJ; Lin Y; Shih WJ; Shull JD; Safe S; Yang CS; Suh N
Cancer Prev Res (Phila); 2015 Sep; 8(9):807-16. PubMed ID: 26130252
[TBL] [Abstract][Full Text] [Related]
8. Characterization of a preclinical model of simultaneous breast and ovarian cancer progression.
Ting AY; Kimler BF; Fabian CJ; Petroff BK
Carcinogenesis; 2007 Jan; 28(1):130-5. PubMed ID: 16891317
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of estradiol-induced mammary proliferation by dibenzoylmethane through the E2-ER-ERE-dependent pathway.
Lin CC; Tsai YL; Huang MT; Lu YP; Ho CT; Tseng SF; Teng SC
Carcinogenesis; 2006 Jan; 27(1):131-6. PubMed ID: 16051634
[TBL] [Abstract][Full Text] [Related]
10. Testosterone inhibits estrogen-induced mammary epithelial proliferation and suppresses estrogen receptor expression.
Zhou J; Ng S; Adesanya-Famuiya O; Anderson K; Bondy CA
FASEB J; 2000 Sep; 14(12):1725-30. PubMed ID: 10973921
[TBL] [Abstract][Full Text] [Related]
11. Proliferative effects of combination estrogen and progesterone replacement therapy on the normal postmenopausal mammary gland in a murine model.
Raafat AM; Hofseth LJ; Haslam SZ
Am J Obstet Gynecol; 2001 Feb; 184(3):340-9. PubMed ID: 11228484
[TBL] [Abstract][Full Text] [Related]
12. Effect of c-neu/ ErbB2 expression levels on estrogen receptor alpha-dependent proliferation in mammary epithelial cells: implications for breast cancer biology.
Shyamala G; Chou YC; Cardiff RD; Vargis E
Cancer Res; 2006 Nov; 66(21):10391-8. PubMed ID: 17079459
[TBL] [Abstract][Full Text] [Related]
13. Effects of daidzein, genistein, and 17beta-estradiol on 7,12-dimethylbenz[a]anthracene-induced mutagenicity and uterine dysplasia in ovariectomized rats.
Aidoo A; Bishop ME; Shelton SD; Lyn-Cook LE; Chen T; Manjanatha MG
Nutr Cancer; 2005; 53(1):82-90. PubMed ID: 16351510
[TBL] [Abstract][Full Text] [Related]
14. Myc/p53 interactions in transgenic mouse mammary development, tumorigenesis and chromosomal instability.
McCormack SJ; Weaver Z; Deming S; Natarajan G; Torri J; Johnson MD; Liyanage M; Ried T; Dickson RB
Oncogene; 1998 May; 16(21):2755-66. PubMed ID: 9652742
[TBL] [Abstract][Full Text] [Related]
15. Estrogen-mediated signaling is differentially affected by the expression levels of Sfrp1 in mammary epithelial cells.
Gregory KJ; Schneider SS
Cell Biol Int; 2015 Jul; 39(7):873-9. PubMed ID: 25809273
[TBL] [Abstract][Full Text] [Related]
16. Detection of ductal dysplasia in mammary outgrowths derived from carcinogen-treated virgin female BALB/c mice.
Ethier SP; Ullrich RL
Cancer Res; 1982 May; 42(5):1753-60. PubMed ID: 6802483
[TBL] [Abstract][Full Text] [Related]
17. Progesterone induces side-branching of the ductal epithelium in the mammary glands of peripubertal mice.
Atwood CS; Hovey RC; Glover JP; Chepko G; Ginsburg E; Robison WG; Vonderhaar BK
J Endocrinol; 2000 Oct; 167(1):39-52. PubMed ID: 11018751
[TBL] [Abstract][Full Text] [Related]
18. Estrogen receptor beta growth-inhibitory effects are repressed through activation of MAPK and PI3K signalling in mammary epithelial and breast cancer cells.
Cotrim CZ; Fabris V; Doria ML; Lindberg K; Gustafsson JÅ; Amado F; Lanari C; Helguero LA
Oncogene; 2013 May; 32(19):2390-402. PubMed ID: 22751110
[TBL] [Abstract][Full Text] [Related]
19. BRCA1-associated mammary tumorigenesis is dependent on estrogen rather than progesterone signaling.
van de Ven M; Liu X; van der Burg E; Klarenbeek S; Alexi X; Zwart W; Dijcks F; Bouwman P; Jonkers J
J Pathol; 2018 Sep; 246(1):41-53. PubMed ID: 29877575
[TBL] [Abstract][Full Text] [Related]
20. Synergistic effects of androgen and estrogen on the mouse uterus and mammary gland.
Zhang J; Sun Y; Liu Y; Sun Y; Liao DJ
Oncol Rep; 2004 Oct; 12(4):709-16. PubMed ID: 15375489
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
